Device Trial Radar · NCT07291427
Chronic Subdural Hematoma Embolization With Detachable Coils
Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Jun 2, 2026
Primary completion
Sep 1, 2028
Study completion Sep 1, 2028
Sponsor
- Lead sponsor
- Icahn School of Medicine at Mount SinaiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- John Muir Health; Carondelet Neurological Institute; Balt USA
- First posted
- Dec 18, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multi-center, post market registry study designed to evaluate the safety and efficacy of treatment with Balt coils in patients with chronic subdural hematoma (cSDH).
Conditions
- Chronic Subdural Hemorrhage (cSDH)
Interventions
Balt coils: (Balt USA, LLC)Device
MMA embolization utilizing Balt Coils
MMA embolizationProcedure
surgical or bedside evacuation pre or post-surgical debridement
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in hematoma volumeTime frame: 180 days
4 more outcomes with a free account
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Carondelet Neurological Institute
Tucson, Arizona · Not yet recruiting
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.